Ключевые слова:
yo’g’on ichak saratoni, CDKN2A genining metillanishi, erta tashxis.Библиографические ссылки
1. Draht M, Goudkade D, Koch A et al. Prognostic DNA meth- ylation markers. Clin Epigenetics.2018;10:35.
2. El Kadmiri N. Advances in early detection of col- orectal cancer: non-invasive biomarkers. Curr Drug Tar- gets.2021;22(9):1043-53.
3. Filho AM, Laversanne M, Ferlay J et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer.2025;156(7):1336-46.
4. Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev.2010;29(1):181-206.
5. Laugsand EA, Brenne SS, Skorpen F. DNA methylation markers in blood, stool, urine, and tissue. Int J Colorectal Dis.2021;36(2):239-51.
6. Li C, Liu Y, Xue D, Chan CWH. Early detection interven- tions. Int J Nurs Stud.2020;110:103684.
7. Matsubara N. CIMP in colorectal carcinogenesis. Gan To Kagaku Ryoho. 2010;37(9):1659-64.
8. Shima K, Nosho K, Baba Y et al. CDKN2A methylation and loss of expression. Int J Cancer.2011;128(5):1080-94.
9. Tillyashaykhov MN, Ibragimov ShN, Djanklich SM; edi- tors. The state of oncological care for the population of the Re- public of Uzbekistan in 2024. Tashkent: Halk Publishing House 2025:189.
10. Tonini V, Zanni M. Why is early detection of colon cancer still not possible in 2023 World J Gastroenterol. 2024;30(3):211–224.
11. Viscaino M, Torres-Bustos J, Muñoz P et al. Artificial intelligence for early CRC detection. Wld J Gastroenter- ol.2021;27(38):6399-414.
12. Xing X, Cai W, Shi H et al. CDKN2A hypermethylation me- ta-analysis. Brit J Cancer.2013;108(12):2542-8.
